Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation

被引:23
|
作者
Welsh, Robert C. [1 ]
Cockfield, Sandra M. [1 ]
Campbell, Patrica [1 ]
Hervas-Malo, Marilou [1 ]
Gyenes, Gabor [1 ]
Dzavik, Vladamir [2 ]
机构
[1] Univ Alberta, Dept Med, Edmonton, AB, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
关键词
Cardiac risk assessment; Renal transplantation; Imaging; CHRONIC KIDNEY-DISEASE; CORONARY-ANGIOGRAPHY; CANDIDATES; MORTALITY; SURGERY;
D O I
10.1097/TP.0b013e3181ff4f61
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although consensus guidelines for preoperative cardiovascular (CV) assessment exist, diabetic patients with renal insufficiency (DM/RI) undergoing assessment for renal transplantation are a unique high-risk group that remains poorly investigated. Methods. A consecutive cohort of DM/RI patients being assessed for renal transplantation was studied. We analyzed the ability of clinical characteristics and noninvasive investigation to predict significant coronary artery disease (CAD) and incidence of major adverse CV events. Results. Baseline characteristics (n = 280) are as follows: mean age 48.6 years (+/- 11.5 standard deviation), 66% men, diabetes duration 22.6 years (mean +/- 8.9 standard deviation), 92% hypertension, 46% hypercholesterolemia, 24% family history CAD, and 21% known CAD. Abnormal myocardial perfusion imaging was found in 27.8%, and 56.5% had CAD more than or equal to 50%. Although positive myocardial perfusion imaging was the only independent predictor of CAD (odds ratio 7.18, 95% confidence interval 2.98-17.3), a poor negative predicted value was observed with normal imaging in 50.3% of patients having CAD more than or equal to 50%, 35.4% CAD more than 70%, and 41.8% Duke angiographic score more than or equal to 4. At mean follow up of 4 years (median 3.9), 76 of 280 patients suffered major adverse cardiovascular events including 17% mortality. Angiographic evidence of CAD (>= 70% odds ratio 1.81, 95% confidence interval 1.02-3.23) was the only independent predictor of major adverse cardiac events. Conclusion. DM/RI patients being assessed for renal transplantation have frequent CV risk factors, high likelihood of CAD, and a 28% incidence of major adverse cardiac events after 4 years. Myocardial perfusion imagining is of little clinical utility as a screening tool for CAD in this population. Only angiographic CAD was predictive of subsequent major adverse cardiac events. Further studies of risk stratification and revascularization in this high-risk population are warranted.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 50 条
  • [21] Bariatric Surgery as a Bridge to Renal Transplantation in Patients with End-Stage Renal Disease
    Al-Bahri, Shadi
    Fakhry, Tannous K.
    Gonzalvo, John Paul
    Murr, Michel M.
    [J]. OBESITY SURGERY, 2017, 27 (11) : 2951 - 2955
  • [22] Pulmonary hypertension in end-stage renal disease and post renal transplantation patients
    Alhamad, Esam H.
    Al-Ghonaim, Mohammed
    Alfaleh, Hussam F.
    Cal, Joseph P.
    Said, Nazmi
    [J]. JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 606 - 616
  • [23] THE EFFECT OF RENAL TRANSPLANTATION ON ERECTILE FUNCTIONS IN PATIENTS WITH END-STAGE RENAL DISEASE
    Karadag, Serdar
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E602 - E603
  • [24] Bariatric Surgery as a Bridge to Renal Transplantation in Patients with End-Stage Renal Disease
    Shadi Al-Bahri
    Tannous K. Fakhry
    John Paul Gonzalvo
    Michel M. Murr
    [J]. Obesity Surgery, 2017, 27 : 2951 - 2955
  • [25] Pulmonary Hypertension in Patients With End-Stage Renal Disease Undergoing Renal Transplantation
    Bozbas, S. S.
    Akcay, S.
    Altin, C.
    Bozbas, H.
    Karacaglar, E.
    Kanyilmaz, S.
    Sayin, B.
    Muderrisoglu, H.
    Haberal, M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (07) : 2753 - 2756
  • [26] Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients
    Zaoui, P.
    Hannedouche, T.
    Combe, C.
    [J]. NEPHROLOGIE & THERAPEUTIQUE, 2017, 13 : 6S16 - 6S24
  • [27] DIABETIC END-STAGE RENAL-DISEASE
    HUMPHREY, LL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (14): : 1008 - 1009
  • [28] END-STAGE RENAL-DISEASE IN DIABETIC
    JOHNSON, WJ
    [J]. MAYO CLINIC PROCEEDINGS, 1977, 52 (05) : 335 - 336
  • [29] Diabetic myonecrosis in end-stage renal disease
    Naredi, Mohit
    Adhikari, Navneet
    Bhardwaj, Gaurav Prakash
    Saxena, Sanjeev
    Bansal, Ravi
    Sharma, Ankit
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2021, 34 (04): : 206 - 210
  • [30] PREVALENCE AND PROGNOSTIC FACTORS FOR ERECTILE DYSFUNCTION IN END-STAGE RENAL DISEASE PATIENTS BEFORE AND AFTER RENAL TRANSPLANTATION
    Qiao, Q.
    Xin, X.
    Liu, L.
    Zang, Z.
    Tan, T.
    Lu, L.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 141 - 141